Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01515475 · ClinicalTrials.gov registry record · NA
Hyperopia Treatment Study 1 (HTS1) - Glasses vs Observation
A NA study of Hyperopia, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- NA
- Development phase
- 249
- Enrollment target
- 2
- Study locations
NCT01515475: Completed NA study of Hyperopia, sponsored by Jaeb Center for Health Research.
NCT01515475 is a NA study of Hyperopia that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 249 participants, above the 99-participant average among 10 other Hyperopia trials with a reported enrollment target (152% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01515475, a NA study of Hyperopia, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 249 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to compare visual acuity outcomes and development of strabismus after a 3-year follow-up period in children age 12 to \<72 months with moderate hyperopia (spherical equivalent +3.00D to +6.00D) who are prescribed glasses either immediately or only after confirmation of pre-specified deterioration criteria.
Primary Outcome
At the 36-month visit, each subject's condition will be classified as either failure or not a failure. The primary analytic approach will be a treatment group comparison of the proportion meeting failure criteria at 36-months using the Fisher's exact test. The participant met failure criteria if ANY of the following criteria (except strabismus surgery prior to the 3-year outcome exam) were met during testing at the 3-year examination both with and without trial frames (without prism or bifocal)
Conditions Studied
Interventions
- PROCEDURE Glasses
Study Locations (2)
Ohio
- The Ohio State University College of Optometry - Columbus
Utah
- Rocky Mountain Eye Care Associates - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 249 participants |
| Start Date | 2012-02-23 |
| Est. Completion | 2018-02 |
| Phase | NA |
What the finished NCT01515475 record still lists
NCT01515475 is an interventional study that assigns participants to a tested intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap, above the 99-participant average among 10 other Hyperopia trials with a reported enrollment target (152% higher).
The record links to 1 condition, with Hyperopia appearing as the primary indexed condition, and to 1 intervention - of which Glasses is the first listed.
NCT01515475 reports a single indexed study location in Ohio, Utah.
Frequently Asked Questions
What is clinical trial NCT01515475 about?
NCT01515475 is a clinical study titled "Hyperopia Treatment Study 1 (HTS1) - Glasses vs Observation". The purpose of this study is to compare visual acuity outcomes and development of strabismus after a 3-year follow-up period in children age 12 to \<72 months with moderate hyperopia (spherical equivalent +3.00D to +6.00D) who are prescribed glasses either immediately or only after confirmation of p...
What is the current status of trial NCT01515475?
This trial is currently completed. It is a NA study. The enrollment target is 249 participants. The study started on 2012-02-23. Estimated completion is 2018-02.
What conditions does trial NCT01515475 study?
This clinical trial studies the following conditions: Hyperopia.
What interventions are being tested in trial NCT01515475?
The interventions under investigation include: Glasses (PROCEDURE).
Who is sponsoring clinical trial NCT01515475?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01515475 being conducted?
This trial has 2 study locations across Ohio, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01515475's enrollment target sits among peer trials
249 2nd of 10 the highest of 10 other Hyperopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hyperopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without Astigmatism
ACTIVE NOT RECRUITING · NA
-
Clinical Investigation of the WaveLight® EX500 Excimer Laser
COMPLETED · NA
-
Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refractive Errors
COMPLETED · NA
-
A Study to Evaluate the Safety and Effectiveness of the Technols 217z Zyoptix System for Hyperopia
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04628767 · 249 participants · Phase 2
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
- NCT05834907 · 249 participants · NA
Hands and Hearts Together
- NCT06067555 · 249 participants · Early Phase 1
Intradermal Influenza Vaccination
- NCT06588478 · 249 participants · Phase 2
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI